Skip to Main Content

Author Details

Irbaz Bin Riaz
Mayo Clinic
2012
128
25
PMIDPaper TitleJournal TitlePublished Year
36862387First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysis.JAMA Oncol2023
37486628Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis.JAMA Netw Open2023
38072760Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.Eur Urol Oncol2023
37658330Empirical evaluation of language modeling to ascertain cancer outcomes from clinical text reports.BMC Bioinformatics2023
37289549Partial breast irradiation compared with whole breast irradiation: a systematic review and meta-analysis.J Natl Cancer Inst2023
37285641Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis.Leuk Res2023
36980557Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach.Cancers (Basel)2023
36889900Proposed triggers for retiring a living systematic review.BMJ Evid Based Med2023
36574777Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.Thromb Haemost2023
36416812Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.JAMA Oncol2023
34172290Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis.Mayo Clin Proc2022
35508401Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis.Heart2022
35508320PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.BMJ2022
35508321PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.BMJ2022
35377484Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials.Cancer2022
35537621Quantifying absolute benefit for adjuvant treatment options in renal cell carcinoma: A living interactive systematic review and network meta-analysis.Crit Rev Oncol Hematol2022
35421369Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.Lancet Oncol2022
35416993Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.JAMA Netw Open2022
35552310The role of chemotherapy in metastatic prostate cancer.Curr Opin Urol2022
35483426Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials.Am J Med2022
36936552Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies.BMJ Med2022
36239399The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis.Oncologist2022
35917480Assessment of Electronic Health Record for Cancer Research and Patient Care Through a Scoping Review of Cancer Natural Language Processing.JCO Clin Cancer Inform2022
35294031Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.Oncologist2022
34463919Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis.J Thromb Thrombolysis2022
34294873Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer.Prostate Cancer Prostatic Dis2022
33012577Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and Cisplatin.Eur Urol2021
33830179Comparison of Therapy in Advanced Hepatocellular Carcinoma Based on Clear Definition and Accurate Subgroup Data-Reply.JAMA Oncol2021
33824031A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma.Eur Urol2021
33840525Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis.Mayo Clin Proc2021
33753042The Cardiovascular Physical Examination - Is It Still Relevant?Am J Cardiol2021
33579544Corrigendum to 'Health Behaviors among Stroke Survivors in the United States: A Propensity Score-Matched Study' [Journal of Stroke & Cerebrovascular Diseases, Vol. 27, No. 8 (August), 2018: pp 2124-2133].J Stroke Cerebrovasc Dis2021
34911934Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset.Nat Commun2021
34043431Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: A Concluded Living Systematic Review and Meta-Analysis.JCO Clin Cancer Inform2021
34171206Bladder cancer: shedding light on the most promising investigational drugs in clinical trials.Expert Opin Investig Drugs2021
33316248Contemporary Management of Pancreatic Cancer from an Internist Perspective.Am J Med2021
30445578The Influence of Depression on Health Care Expenditures Among Adults with Spondylosis, Intervertebral Disc Disorders, and Other Back Problems in the United States.Pain Med2020
32048924Gender Differences in Faculty Rank and Leadership Positions Among Hematologists and Oncologists in the United States.JCO Oncol Pract2020
32048920Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab.JCO Oncol Pract2020
31682981Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant Recipients.Biol Blood Marrow Transplant2020
31913498Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis.Cancer2020
33091355Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis.Lancet Haematol2020
32805168In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding.Ann Intern Med2020
32446852A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer.Clin Lung Cancer2020
32301992Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals.JAMA Netw Open2020
32313882Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution.Ann Pancreat Cancer2020
32221021External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.Int J Gynecol Cancer2020
31588557Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.Cancer2020
28594339Cardiac Dysrhythmias Associated With Substitutive Use of Loperamide: A Systematic Review.Am J Ther2019
31685262Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis.Mayo Clin Proc2019
  • 1 - 50 of 128

Recommended Authors

Mayo Clinic
Career Start Year 2018
Number of shared co-authors 3
Weill Cornell Medical College
Career Start Year 2017
Number of shared co-authors 0
Princess Margaret Hospital
Career Start Year 2017
Number of shared co-authors 0
Mayo Clinic Arizona
Career Start Year 2015
Number of shared co-authors 1
Loyola University, Illinois Edward Hines Veteran Affairs Hospital
Career Start Year 2011
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 1
University of Toronto
Career Start Year 2010
Number of shared co-authors 0
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 0
Universite Paris-Cite, INSERM
Career Start Year 2006
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 1
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 4
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Texas A&M University College of Medicine
Career Start Year 1995
Number of shared co-authors 0
University Health Network
Career Start Year 1994
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 1
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Nagasaki University Graduate School of Biomedical Sciences
Career Start Year 1989
Number of shared co-authors 0
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 1
University of South Carolina
Career Start Year 1986
Number of shared co-authors 3
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 4
Juravinski Hospital and Cancer Center
Career Start Year 1983
Number of shared co-authors 0
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

University of Arizona
Co-authored papers 19
Evidence Foundation
Co-authored papers 16
Banner University Medical Center, University of Arizona
Co-authored papers 12
Mayo Clinic
Co-authored papers 9
University of Toledo
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Mayo Clinic
Co-authored papers 6
Lovisenberg Diaconal Hospital
Co-authored papers 6
Vanderbilt University Medical Center
Co-authored papers 5
University of Sheffield and Sheffield Teaching Hospitals
Co-authored papers 5
Mayo Clinic Arizona
Co-authored papers 4
University of Virginia Health System
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
The Mayo Clinic
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Memorial-Sloan Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Mayo Clinic
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
CVPath Institute
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
The First Medical Center of PLA General Hospital
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
University of Texas Health Science Center at Houston, Mayo Clinic
Co-authored papers 1
Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic
Co-authored papers 1
Dow University of Health Sciences
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Mayo Clinic
Co-authored papers 1